Destination Therapy Strategies of Advanced Heart Failure in Elderly Non-Heart Transplant Candidates: A Propensity Matching Analysis from the LEVO-D and REGALAD Registries

Heart transplantation (HT) is the gold standard therapy for advanced heart failure (ADHF), and LVADs as destination therapy are an option in non-HT candidates. Most patients with ADHF never receive HT or an LVAD, so alternative strategies are needed. Intermittent levosimendan can reduce HF hospitali...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	David Dobarro, Sergio Raposeiras-Roubin, Luis Almenar-Bonet, Eduard Solé-González, Mireia Padilla-Lopez, Carles Diez-Lopez, Javier Castrodeza, Maria Dolores García-Cosío, Marta Cobo-Marcos, Javier Tobar, Pau Codina, Silvia Lopez-Fernandez, Francisco Pastor, Diego Rangel-Sousa, Eduardo Barge-Caballero, Beatriz Diaz-Molina, Alfredo Barrio-Rodriguez, Virginia Burgos-Palacios, Jesús Álvarez-García, Oscar González-Fernández, Andrés Grau-Sepulveda, José Manuel Garcia-Pinilla, Sonia Ruiz-Bustillo, Ana B. Mendez-Fernández, David Vaqueriza-Cubillo, Igor Sagasti-Aboitiz, Miguel Rodriguez-Santamarta, Ainara Lozano-Bahamonde, Ana Abecia, Inés Gómez-Otero, Raquel Marzoa, Eva González-Babarro, Manuel Gómez-Bueno, José Gonzalez-Costello
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	MDPI AG 2024-11-01
Reeks:	Life
Onderwerpen:	advanced heart failure LVAD inotropes
Online toegang:	https://www.mdpi.com/2075-1729/14/12/1570
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!